Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study.
about
Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapyEchocardiography-based left ventricular mass estimation. How should we define hypertrophy?Cardiovascular changes during chronic hypertensive statesExtreme sacrifice: sudden cardiac death in the US Fire ServiceCyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytesTraditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis.Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart AssociationRelationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults.Cardiac and vascular consequences of pre-hypertension in youth.Implications of the LIFE trial.Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension.Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study.Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study.Pre-clinical and clinical experience of telmisartan in cardiac remodelling.Addition of highly sensitive troponin T and N-terminal pro-B-type natriuretic peptide to electrocardiography for detection of left ventricular hypertrophy: results from the Dallas Heart StudySequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathyLeft Ventricular Hypertrophy Phenotype in Childhood-Onset Essential Hypertension.Quantitative assessment of systolic left ventricular function with speckle-tracking echocardiography in adult patients with repaired aortic coarctation.Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study).Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA)Relationship between left ventricular geometric pattern and systolic and diastolic function in treated Nigerian hypertensives.Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fractionLeft ventricular hypertrophy and clinical outcomes in hypertensive patients.Atrial natriuretic Peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation.Unmet needs in managing hypertension: potential role of direct renin inhibition.Association between left ventricular mass index and cardiac function in pediatric dialysis patients.Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies.Hypertension in the US Black population: risk factors, complications, and potential impact of central aortic pressure on effective treatment.HIF-prolyl hydroxylases and cardiovascular diseases.Hypertension as a risk factor for heart failure.Myocardial remodeling in hypertension.Biomarkers in hypertension and their relationship with myocardial target-organ damage.Novel Index of Maladaptive Myocardial Remodeling in HypertensionBetter Indigenous Risk stratification for Cardiac Health study (BIRCH) protocol: rationale and design of a cross-sectional and prospective cohort study to identify novel cardiovascular risk indicators in Aboriginal Australian and Torres Strait IslanPredictive Performance of Echocardiographic Parameters for Cardiovascular Events Among Elderly Treated Hypertensive Patients.Increased mobilization of mesenchymal stem cells in patients with essential hypertension: the effect of left ventricular hypertrophy.Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.Youth with type 1 diabetes have worse strain and less pronounced sex differences in early echocardiographic markers of diabetic cardiomyopathy compared to their normoglycemic peers: A RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) SUse of predictive markers to improve cardiovascular protection.Atenolol vs enalapril in young hypertensive patients after successful repair of aortic coarctation.
P2860
Q24803588-655DCE29-735C-4138-A939-9A3A4DBC8ACAQ24810969-03080C97-A68A-41AD-8B70-7D7969045D5CQ26827799-D5376685-E5D4-44A6-911D-4812DC6E8FC9Q28385633-AB8B6E47-5FE0-4C30-AC3D-3A9C07F796D5Q28565260-94CA4C97-F839-4E26-9CE3-439679294246Q30499545-E14F4775-A343-48D9-85DE-6E95F44FF145Q30586389-11985E60-BB6B-483C-80DE-BDAD25AEF99DQ34785747-06325ED8-0423-466C-9460-9C3FDF4371FAQ34971967-486D8989-6644-4D96-A341-BA1874436952Q35117105-B6AFB8A9-AACB-46FB-A98C-52A51CD31DE9Q35463556-EBA0EEDB-4CB3-4767-B73E-7AF7738E23C5Q35865788-3CC88A5B-C490-4E6C-AC25-91FC71F0C1ACQ35903365-3119ED0E-8E59-4B8E-A461-494D60AB66D8Q36285372-8BC77AB0-5ED1-4822-920D-88959AA35991Q36465527-760400B0-1B24-4278-AD99-4DD048F96A38Q36766849-C0965B1A-6C30-4BCA-A1A8-8BA4D1C45EDDQ36768148-CA048422-AA28-4AF6-A0EE-818BE04A3F84Q36859213-4DC9707D-047C-4E38-966E-8BD8533BE5F2Q36974119-940A10BE-A8DE-4210-9192-D6811446AB11Q37002467-BDA733F2-9673-469B-A1E6-527DEAA6DA83Q37040960-59056D66-93C8-4455-8E0F-D50040E1EA64Q37060522-7686B609-70D6-4AF9-9EB8-83C98B892113Q37147735-84B4203A-42FA-4E35-9347-1E1F51948B99Q37195866-E87EAB89-F1E0-4D26-92FA-3DFB83994C64Q37750291-6B5E4F2A-322C-4D4E-83F1-24DF6459BB58Q37959381-08BF0D30-E038-49C4-8B17-BD6F1D537DB4Q37960351-78C24F8E-DEF9-4ACF-A46A-1E28304EBEAFQ37975922-CCEFF536-014F-4D56-9908-9DEDAE43CD21Q37994258-A0CF8CE1-6CEB-49C5-98ED-F2AE81B763B3Q38208967-0227225A-F5B4-479A-865A-A4774278013DQ38209968-1B345A85-3D14-4998-96DB-FEDC36769FBEQ38258970-A8FABDCF-D352-4C22-959B-A8ED35CAB8BBQ38371573-B858E627-7C5E-4AD6-BD65-2D43FEBAB87DQ38611359-32F48514-AD4A-4239-94C3-D85DEFE2FA8AQ38875978-E7B5B856-57EB-44A8-92E5-82037D45FE11Q39110627-7AEA7296-922F-4FCB-9891-37FE290883C0Q39390119-82B2F9AD-72AF-4145-AF30-3222DE80B19FQ39805797-45CF53C0-AE50-4CBE-ABB1-1B53A57090FBQ40199205-259F6E7F-F55D-451B-83CB-D66FA780FE5BQ40625480-721B1FB5-A32A-4B68-B43E-BE1440CA5ABF
P2860
Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Left ventricular mass and card ...... hypertension: the MAVI study.
@en
Left ventricular mass and card ...... hypertension: the MAVI study.
@nl
type
label
Left ventricular mass and card ...... hypertension: the MAVI study.
@en
Left ventricular mass and card ...... hypertension: the MAVI study.
@nl
prefLabel
Left ventricular mass and card ...... hypertension: the MAVI study.
@en
Left ventricular mass and card ...... hypertension: the MAVI study.
@nl
P2093
P1476
Left ventricular mass and card ...... hypertension: the MAVI study.
@en
P2093
A P Maggioni
E Dovellini
E Giovannini
M Lombardo
MAVI (MAssa Ventricolare sinistra nell'Ipertensione) Study Group
P Verdecchia
P304
P356
10.1016/S0735-1097(01)01663-1
P407
P577
2001-12-01T00:00:00Z